Pharmacodynamics describes what a medicinal product does in the body. It examines the relationship between active substance concentration and biological effect—including desired effects and adverse effects.
Together with pharmacokinetics (what the body does to the medicinal product), pharmacodynamics forms the basis for dosing, demonstration of efficacy, and safety assessment.
What is considered in pharmacodynamics?
Depending on the mechanism of action, pharmacodynamic analyses can look very different. Commonly, they focus on:
- Target binding (e.g., receptor, enzyme, or transporter binding)
- Signaling pathways and downstream biological processes
- Dose–response relationships (e.g., Emax model)
- Therapeutic window and adverse effect profile
Dose–response relationship
A key concept is how strongly the effect increases as dose or concentration rises. A saturation effect is typical: beyond a certain concentration, the effect increases only minimally.
Key parameters include, for example:
- Emax: maximum achievable effect
- EC50: concentration at which 50% of the maximum effect is achieved
Measures and endpoints
Pharmacodynamics often uses biomarkers and functional measures, such as laboratory values, physiological parameters, or imaging markers. In clinical trials, pharmacodynamics can help demonstrate mechanistic plausibility or narrow down dose ranges.
Relevance in drug development
Pharmacodynamic data are used to:
- justify a starting dose and dose escalation (especially Phase I)
- determine the effective dose for Phase II/III studies
- better understand risks and on-target/off-target adverse effects
- use PK/PD models for simulations and dose optimization
FAQ
What is the difference between pharmacokinetics and pharmacodynamics?
Pharmacokinetics describes absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics describes the effect and mechanism of action of the medicinal product.
Why is pharmacodynamics important for adverse effects?
Adverse effects may arise through the same mechanism as the desired effect (on-target) or through other targets (off-target). Pharmacodynamic analyses help identify these patterns.
Can pharmacodynamics be measured without plasma concentrations?
Yes. Some effects can be measured directly as functional outcomes (e.g., blood pressure), even if no concentration measurement is available. However, concentration data are often particularly helpful for PK/PD models.